BCART — Biocartis NV Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Brief: Biocartis Announces Market Release Of SeptiCyte® RAPID Test On Idylla™
Brief: Biocartis Gets EUR 1.2 Mln Grant For Idylla GeneFusion Assay
Brief: Biocartis H1 Net Loss Widens To EUR 31.6 Million
Brief: Biocartis Expands Its Collaboration With LifeArc On Idylla Platform
Brief: Biocartis Group Says Idylla™ Allows Rapid and Accurate Mutation Testing Results
Brief: Biocartis Creates New Share Option Plan
Brief: Biocartis Suspends Guidance, Appoints New CFO
Commercialisation Agreement For SeptiCyte RAPID Test
Brief: Biocartis Group FY Total Operating Income Up At 37.7 Million Euros
Brief: Biocartis Creates New Share Option Plan
Brief: Biocartis: New Immuno-Oncology Project With Bristol-Myers Squibb
Brief: Biocartis Announces Resignation CFO
Brief: Biocartis Enters Into Collaboration Agreement With Astrazeneca
Brief: Biocartis Announces Achievement Of Its 2019 Objectives
Brief: Biocartis Group Q3 Cash Position Up At 197 Million Euros
Brief: Biocartis Updates On EUR 150 Mln Senior Unsecured Convertible Bonds
Brief: Biocartis Updates on Five Idylla Studies
Brief: Biocartis Launches Liquid Biopsy Idylla ctEGFR Mutation Assay
Brief: Biocartis: 5 Idylla Performance Studies To Be Presented At Congress